Can mildly elevated ALT accompany fatty liver and hepatic insulin resistance?

Mild ALT elevation is compatible with metabolic liver disease but is not diagnostic of it. The overall claim is clinically sound: ALT and AST are imperfect injury markers, not direct measures of liver fat or hepatic insulin action.

Clinical and metabolic evidence

• In obese adults without diabetes, ALT correlated with intrahepatic triglyceride measured by magnetic-resonance spectroscopy (r=0.647). Greater liver fat was also associated with lower hepatic insulin sensitivity, assessed from tracer-based endogenous glucose production.
• Higher ALT has been associated with a hepatic insulin-resistance index, greater endogenous glucose output, and reduced insulin-mediated suppression of hepatic glucose production. Thus, mildly raised ALT can accompany both steatosis and hepatic insulin resistance, especially in metabolically abnormal settings.
• These associations are not uniform: in one cohort of 440 adults with NAFLD, elevated ALT tracked with greater liver triglyceride but not with greater hepatic insulin resistance.

Mechanistic interpretation

• Fatty liver and hepatic insulin resistance are closely linked: liver fat accumulation is associated with impaired insulin suppression of hepatic glucose production. ALT may rise in this metabolic context because it reflects hepatocellular injury or stress, but it does not directly quantify hepatic triglyceride or insulin sensitivity.

Diagnostic implications

• ALT alone is nonspecific. It may be elevated with MASLD, alcohol-associated disease, viral hepatitis, medication/supplement injury, autoimmune, inherited, or extrahepatic conditions.
• A normal AST neither establishes nor rules out fatty liver. MASLD/MASH and even advanced fibrosis can occur with normal aminotransferases. AASLD advises that aminotransferases should not be used alone for fibrosis assessment.
• Where clinically indicated, liver-fat evaluation requires imaging or validated noninvasive assessment; fibrosis risk assessment uses FIB-4 followed, when appropriate, by elastography or ELF testing.

Bottom line

• Mild ALT elevation can accompany fatty liver and hepatic insulin resistance, but neither ALT nor normal AST can diagnose, confirm, or exclude fatty liver without clinical context and appropriate confirmatory assessment.